The ad is aimed at President Donald Trump and a specific proposal known as "patient definition" that has been floated in the administration's drug pricing blueprint.
For Tracy Carter, vice president of government relations at Cleveland-based MetroHealth System, protecting Medicaid is intertwined with the public health system's overall mission. In recent budget battles, her team fought off cuts that would have cost MetroHealth nearly $25 million.
New York City's massive public health system has announced a broader strategy to secure its outpatient business and revenue in the face of ongoing financial woes.
The HHS vs. providers' billion-dollar fight over Medicare will head to the Supreme Court this term.
Ochsner Health System will make improvements to the safety-net hospitals in north Louisiana under its new management deal to operate the facilities, the system's CEO said Monday as the oversight contracts were officially signed.
The troubled Indian Health Service hospital on the Rosebud Sioux Reservation has been given another week to improve care conditions or risk losing key federal funding.
Gov. John Bel Edwards' administration has made a deal to transfer oversight of the state-owned safety-net hospitals in north Louisiana to a new manager, with boosted costs and more direct involvement from Louisiana State University.
Hospitals have adopted a take-no-prisoners approach in the fight with Big Pharma over the 340B drug discount program. Can this strategy hold as Congress, oversight agencies, the courts and the Trump administration ratchet up scrutiny of the program?
HHS Secretary Alex Azar in a meeting with several key House GOP lawmakers suggested standardizing the discount for 340B drugs at 20% of list price, far below the current 40% to 60% discount.
Verity Health System announced it is exploring strategic options, including the sale of one or all of its locations, as part of the California system's ongoing effort to relieve financial and operational challenges.
HHS is planning a new rule to set ceiling prices for the 340B drug discount program, despite many delays to implement an earlier rule on the issue.
The CMS has appealed a Missouri federal court's decision that stopped the agency from clawing back money from Missouri hospitals' disproportionate-share hospital allotments.